Astrana Health (NASDAQ:ASTH) Shares Up 3.9% - Here's Why

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) rose 3.9% on Tuesday . The company traded as high as $31.66 and last traded at $31.81. Approximately 130,682 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 249,187 shares. The stock had previously closed at $30.60.

Analysts Set New Price Targets

ASTH has been the subject of several research analyst reports. Bank of America lowered their price objective on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, March 4th. Robert W. Baird lowered their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Macquarie upgraded shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Truist Financial lowered their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research report on Tuesday. Finally, Stifel Nicolaus lowered their price target on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Astrana Health has a consensus rating of "Moderate Buy" and a consensus target price of $56.17.

Astrana Health Trading Up 0.2 %

The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market cap of $1.74 billion, a P/E ratio of 23.76, a PEG ratio of 1.37 and a beta of 1.30. The firm's 50 day moving average is $33.97 and its two-hundred day moving average is $42.56.

Remove Ads

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.22 by ($0.37). The firm had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, equities research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Institutional Trading of Astrana Health

Institutional investors have recently bought and sold shares of the company. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Astrana Health during the fourth quarter valued at about $40,000. Quarry LP raised its holdings in shares of Astrana Health by 35.5% during the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after purchasing an additional 471 shares during the period. KBC Group NV acquired a new position in shares of Astrana Health during the third quarter valued at about $70,000. Quest Partners LLC acquired a new position in shares of Astrana Health during the third quarter valued at about $133,000. Finally, US Bancorp DE raised its holdings in shares of Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after purchasing an additional 4,656 shares during the period. Institutional investors own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.